Topics

• Pharmacogenetics and pharmacogenomics
• Pharmacogenomics resources and databases
• Clinical implementation of pharmacogenetics and pharmacogenomics
• Individualized drug treatment
• Cancer pharmacogenomics
• Novel biomarkers of treatment response
• NGS for pharmacogenomics

Programme (PDF)

Confirmed speakers

• Erika Cecchin, CRO Aviano, Italy
• Ann K. Daly, Newcastle University, United Kingdom
• Vita Dolžan, Faculty of Medicine, University of Ljubljana, Slovenia
• Lana Ganoci, University Hospital Centre Zagreb, Italy
• Vladimir Gašić, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia
• Katja Goričar, Faculty of Medicine, University of Ljubljana, Slovenia
• Magnus Ingelman-Sundberg, Karolinska Institutet, Stockholm, Sweden
• Marina Jelovac, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia
• Nikola Kotur, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia
• Adrian Llerena, Extremadura University Hospital, Badajoz, Spain
• John McDermott, Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, United Kingdom
• William Newman, Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, United Kingdom
• Mikko Niemi, University of Helsinki, Finland
• Cristina Rodriguez-Antona, Spanish National Cancer Research Centre, Madrid, Spain
• Ron van Schaik, Erasmus MC, Rotterdam, The Netherlands
• Julia C. Stingl, Heidelberg University Hospital, Germany
• Branka Zukić, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia